The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians von Knappskog, Stian, Bjørnslett, Merete, Myklebust, Line M., Huijts, Petra E.A., Vreeswijk, Maaike P., Edvardsen, Hege, Guo, Yongli, Zhang, Xuemei, Yang, Ming, Ylisaukko-oja, Sanna K., Alhopuro, Pia, Arola, Johanna, Tollenaar, Rob A.E.M., van Asperen, Christi J., Seynaeve, Caroline, Staalesen, Vidar, Chrisanthar, Ranjan, Løkkevik, Erik, Salvesen, Helga B., Evans, D. Gareth, Newman, William G., Lin, Dongxin, Aaltonen, Lauri A., Børresen-Dale, Anne-Lise, Tell, Grethe S., Stoltenberg, Camilla, Romundstad, Pål, Hveem, Kristian, Lillehaug, Johan R., Vatten, Lars, Devilee, Peter, Dørum, Anne, Lønning, Per E.

Volltext

Oral Contraceptives and the Risk of Hereditary Ovarian Cancer von Narod, Steven A, Risch, Harvey, Moslehi, Roxana, Dørum, Anne, Neuhausen, Susan, Olsson, Hakan, Provencher, Diane, Radice, Paolo, Evans, Gareth, Bishop, Susan, Brunet, Jean-Sébastien, Ponder, Bruce A.J, Klijn, Jan G.M

Volltext

Long-term oncological outcomes and recurrence patterns in early-stage cervical cancer treated with minimally invasive versus abdominal radical hysterectomy: The Norwegian Radium Ho... von Sert, Bilal M., Kristensen, Gunnar B., Kleppe, Andreas, Dørum, Anne

Volltext

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer von González-Martín, Antonio, Pothuri, Bhavana, Vergote, Ignace, DePont Christensen, René, Graybill, Whitney, Mirza, Mansoor R, McCormick, Colleen, Lorusso, Domenica, Hoskins, Paul, Freyer, Gilles, Baumann, Klaus, Jardon, Kris, Redondo, Andrés, Moore, Richard G, Vulsteke, Christof, O’Cearbhaill, Roisin E, Lund, Bente, Backes, Floor, Barretina-Ginesta, Pilar, Haggerty, Ashley F, Rubio-Pérez, Maria J, Shahin, Mark S, Mangili, Giorgia, Bradley, William H, Bruchim, Ilan, Sun, Kaiming, Malinowska, Izabela A, Li, Yong, Gupta, Divya, Monk, Bradley J

Volltext

Cold Atmospheric Pressure Plasma (CAP) as a New Tool for the Management of Vulva Cancer and Vulvar Premalignant Lesions in Gynaecological Oncology von Zubor, Pavol, Wang, Yun, Liskova, Alena, Samec, Marek, Koklesova, Lenka, Dankova, Zuzana, Dørum, Anne, Kajo, Karol, Dvorska, Dana, Lucansky, Vincent, Malicherova, Bibiana, Kasubova, Ivana, Bujnak, Jan, Mlyncek, Milos, Dussan, Carlos Alberto, Kubatka, Peter, Büsselberg, Dietrich, Golubnitschaja, Olga

Volltext

MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk von Knappskog, Stian, Gansmo, Liv B, Romundstad, Pål, Bjørnslett, Merete, Trovik, Jone, Sommerfelt-Pettersen, Jan, Løkkevik, Erik, Tollenaar, Rob A E M, Seynaeve, Caroline, Devilee, Peter, Salvesen, Helga B, Dørum, Anne, Hveem, Kristian, Vatten, Lars, Lønning, Per E

Volltext

Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer von Gansmo, Liv B., Sofiyeva, Nigar, Bjørnslett, Merete, Romundstad, Pål, Hveem, Kristian, Vatten, Lars, Dørum, Anne, Lønning, Per E., Knappskog, Stian

Volltext

Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist) von Lindemann, Kristina, Gibbs, Emma, Åvall-Lundqvist, Elisabeth, dePont Christensen, Rene, Woie, Kathrine, Kalling, Marten, Auranen, Annika, Grenman, Seija, Hoegberg, Thomas, Rosenberg, Per, Skeie-Jensen, Tone, Hjerpe, Elisabet, Dørum, Anne, Gebski, Val, Kristensen, Gunnar

Volltext

Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study von O'Cearbhaill, Roisin E., Pérez-Fidalgo, Jose-Alejandro, Monk, Bradley J., Tusquets, Ignacio, McCormick, Colleen, Fuentes, Jose, Moore, Richard G., Vulsteke, Christof, Shahin, Mark S., Forget, Frédéric, Bradley, William H., Hietanen, Sakari, O'Malley, David M., Dørum, Anne, Slomovitz, Brian M., Baumann, Klaus, Selle, Frédéric, Calvert, Paula M., Artioli, Grazia, Levy, Tally, Kumar, Aalok, Malinowska, Izabela A., Li, Yong, Gupta, Divya, González-Martín, Antonio

Volltext

Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial von Fabbro, Michel, Moore, Kathleen N., Dørum, Anne, Tinker, Anna V., Mahner, Sven, Bover, Isabel, Banerjee, Susana, Tognon, Germana, Goffin, Frederic, Shapira-Frommer, Ronnie, Wenham, Robert M., Hellman, Kristina, Provencher, Diane, Harter, Philipp, Vázquez, Isabel Palacio, Follana, Philippe, Pineda, Mario J., Mirza, Mansoor R., Hazard, Sebastien J., Matulonis, Ursula A.

Volltext

Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancer von Elgaaen, Bente Vilming, Dahl, Jørgen Fallås, Bentzen, Anne Gry, Ingebrigtsen, Vibeke Anett, Nilsen, Elisabeth Berge, Vistad, Ingvild, Dørum, Anne, Popova, Olesya, Bjørge, Line, Zucknick, Manuela, Aune, Guro, Lindemann, Kristina Yvonne Kathe

Volltext

Base rate of ovarian cancer on algorithms in patients with a pelvic mass von Rolfsen, Anne Lone Denny, Dahl, Alv A, Pripp, Are Hugo, Dørum, Anne

Volltext

C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease von Landskron, Johannes, Kraggerud, Sigrid M, Wik, Elisabeth, Dørum, Anne, Bjørnslett, Merete, Melum, Espen, Helland, Øystein, Bjørge, Line, Lothe, Ragnhild A, Salvesen, Helga B, Taskén, Kjetil

Volltext

A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway von Vistad, Ingvild, Bjørge, Line, Solheim, Olesya, Fiane, Bent, Sachse, Kurt, Tjugum, Jostein, Skrøppa, Siri, Bentzen, Anne G., Stokstad, Trine, Iversen, Grete A., Salvesen, Helga B., Kristensen, Gunnar B., Dørum, Anne

Volltext

Use of hormone replacement therapy after risk‐reducing salpingo‐oophorectomy von Johansen, Nora, Liavaag, Astrid H., Iversen, Ole‐Erik, Dørum, Anne, Braaten, Tonje, Michelsen, Trond M.

Volltext

Psychological distress related to BRCA testing in ovarian cancer patients von Bjørnslett, Merete, Dahl, Alv A., Sørebø, Øystein, Dørum, Anne

Volltext

MOC31PE immunotoxin - targeting peritoneal metastasis from epithelial ovarian cancer von Andersson, Yvonne, Haavardtun, Synne Ihler, Davidson, Ben, Dørum, Anne, Fleten, Karianne G, Fodstad, Øystein, Flatmark, Kjersti

Volltext

Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer von Helwa, Reham, Gansmo, Liv Beathe, Bjørnslett, Merete Pauline, Halle, Mari Kyllesø, Werner, Henrica Maria Johanna, Romundstad, Pål Richard, Hveem, Kristian, Vatten, Lars Johan, Dørum, Anne, Lønning, Per Eystein, Knappskog, Stian

Volltext

TGFβ splicing and canonical pathway activation in high-grade serous carcinoma von Gutgold, Neriya, Davidson, Ben, Catane, Liora Jacobs, Holth, Arild, Hellesylt, Ellen, Tropé, Claes G., Dørum, Anne, Reich, Reuven

Volltext

A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer von Michelsen, Trond M, Dørum, Anne, Dahl, Alv A

Volltext